Management of hyperlipidaemia. Why, when and how to treat.
作者信息
Oliver M F, Pyörälä K, Shepherd J
机构信息
National Heart & Lung Institute, London, U.K.
出版信息
Eur Heart J. 1997 Mar;18(3):371-5. doi: 10.1093/oxfordjournals.eurheartj.a015257.
Abstract
摘要
相似文献
1
Management of hyperlipidaemia. Why, when and how to treat.高脂血症的管理。为何、何时以及如何进行治疗。
Eur Heart J. 1997 Mar;18(3):371-5. doi: 10.1093/oxfordjournals.eurheartj.a015257.
2
Hyperlipidaemia and coronary risk. The Scottish Lipid Consensus Group.
Scott Med J. 1991 Aug;36(4):99-103. doi: 10.1177/003693309103600401.
3
Importance of hyperlipidaemia and therapy in renal patients.高脂血症在肾病患者中的重要性及治疗
Nephrol Dial Transplant. 2000;15 Suppl 5:92-6. doi: 10.1093/ndt/15.suppl_5.92.
4
Hyperlipidemia in atherosclerosis. Dietary and drug treatment.动脉粥样硬化中的高脂血症。饮食与药物治疗。
Med Clin North Am. 1970 May;54(3):657-69.
5
Treatment of hyperlipidaemia.高脂血症的治疗。
Clin Endocrinol (Oxf). 1993 Apr;38(4):337-42. doi: 10.1111/j.1365-2265.1993.tb00510.x.
6
[Hyperlipidemia complicated with hypertension].
Nihon Rinsho. 2001 Mar;59 Suppl 3:738-42.
7
Management of hyperlipidaemia.高脂血症的管理
Drug Ther Bull. 1996 Dec;34(12):89-93. doi: 10.1136/dtb.1996.341289.
8
Management of dyslipidemia in adults with diabetes. American Diabetes Association.成人糖尿病患者血脂异常的管理。美国糖尿病协会。
Diabetes Care. 1998 Jan;21(1):179-82. doi: 10.2337/diacare.21.1.179.
9
Primary prevention of coronary heart disease: where do we go from here?冠心病的一级预防：我们从这里何去何从？
Arch Intern Med. 2001 Apr 9;161(7):922-4. doi: 10.1001/archinte.161.7.922.
10
[Therapeutic management of the dyslipidemic patient].[血脂异常患者的治疗管理]
Ann Endocrinol (Paris). 2001 Feb;62(1 Pt 1):70-5.
引用本文的文献
1
Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart disease.普伐他汀。对其在冠心病一级和二级预防中应用的药物经济学综述。
Pharmacoeconomics. 1998 Aug;14(2):217-36. doi: 10.2165/00019053-199814020-00010.
Zotero 插件